Navigation Links
Biodel Reports Second Quarter Fiscal Year 2011 Financial Results
Date:5/5/2011

ifying words.  The company's forward-looking statements are subject to a number of known and unknown risks and uncertainties that could cause actual results, performance or achievements to differ materially from those described or implied in the forward-looking statements, including, but not limited to, our ability to respond to the complete response letter regarding our new drug application for Linjeta™ in a timely manner and the possibility that information we provide in response to the letter may not be accepted by the FDA; our ability to secure FDA approval for Linjeta™ and our other product candidates under Section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act; our ability to market, commercialize and achieve market acceptance for product candidates developed using our VIAdel™ technology; the progress or success of our research, development and clinical programs and the initiation and completion of our clinical trials; the possibility that patients taking Linjeta™ may experience more injection site discomfort than they experience with competing products; unexpected data that may result from our clinical trials and our research and development activities; our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others; our estimates of future performance; our ability to enter into collaboration arrangements for the commercialization of our product candidates and the success or failure of those collaborations after consummation, if consummated; the rate and degree of market acceptance and clinical utility of our products; our commercialization, marketing and manufacturing capabilities and strategy; our estimates regarding anticipated operating losses, future revenues, capital requirements and our needs for additional financing; and other factors identified in our most recent annual report on Form 10-Q for the quarter ended December 31, 2010.  The
'/>"/>
SOURCE Biodel Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Biodel to Report Second Quarter Fiscal Year 2011 Financial Results on May 5, 2011
2. BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
3. Biodel Announces Appointment of Dr. Brian J.G. Pereira as Board Chairman; Dr. Charles A. Sanders to Remain on Board
4. Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012
5. BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference
6. Biodel Inc. to Present at the Roth 23rd Annual OC Growth Stock Conference on March 16, 2011
7. BioDelivery Sciences Confirms 505(b)(2) Pathway for BEMA Buprenorphine/Naloxone for Opioid Dependence Following FDA Meeting
8. BioDelivery Sciences Announces BEMA Buprenorphine Phase 3 Chronic Pain Study More Than 50% Recruited and on Schedule
9. Biodel Reports First Quarter Fiscal Year 2011 Financial Results
10. Biodel to Report First Quarter Fiscal Year 2011 Financial Results on February 3, 2011
11. MonoSol Rx, LLC Files Patent Infringement and False Marking Lawsuit Against BioDelivery Sciences International, Inc., MEDA Pharmaceuticals Inc., and Aveva Drug Delivery Systems, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... WEST JORDAN, Utah , Aug. 29, 2014 /PRNewswire/ ... Imaging Solutions, has acquired Polaris Medical Imaging, a leader ... CT scanners. This strategic acquisition allows BC Technical to ... their capabilities, specifically within MR and CT modalities. ... lower cost service," said Mark Alvarez , president ...
(Date:8/29/2014)... Research and Markets has announced the addition ... Pipeline Insight 2014" report to their offering. ... eradicate the prevalence of cancer have achieved limited success ... specificity, safety and large number of side effects, which ... It has been discovered that peptides can be used ...
(Date:8/29/2014)... According to a new ... type (SFE, Cold Pressed, Organic Solvent, & Others), and ... Fragrance, & Others) - Global Trends & Forecast ... the Amaranth Seed Oil Market with an analysis ... of value. The Amaranth Seed Oil Market size ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... SAN DIEGO, May 26, 2011 Volcano Corporation ... following statement: Earlier this year, the ... a wholly-owned subsidiary of St. Jude Medical, that ... misappropriated LightLab,s confidential information in connection for use ...
... YORK, May 26, 2011 A new prostate cancer ... Medicine comparing surgical treatment to "watchful waiting" ... cancer and currently debating their treatment options. ... the most commonly offered clinical options for early prostate ...
Cached Medicine Technology:Statement From Volcano Corporation on Latest St. Jude Lawsuit 2Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment 2Robotic Prostatectomy Expert Dr. David Samadi on a High Impact Study Advocating Aggressive Early-Stage Prostate Cancer Treatment 3
(Date:9/1/2014)... Building on the success of the 2014 ... Breathing Academy (ASBA) has officially announced its 2015 ... The event will be taking place at the DoubleTree ... This years’ event promises to be yet another educational ... In recent years, Pro Player Health Alliance ...
(Date:9/1/2014)... health and substance use problems in adolescents but ... consequences of cyberbullying and also be beneficial for ... Ph.D., of McGill University, Montreal, Canada, and colleagues. ... experienced recent online bullying and cyberbullying, like traditional ... problems in teens as well as the misuse ...
(Date:9/1/2014)... You may be able to convince your brain that healthy ... The study included eight overweight and obese people who were ... how people react to different foods. These participants were compared ... who weren,t in the program. Both groups had MRI ... six months later. The scans revealed that the people in ...
(Date:9/1/2014)... Currently, scientists continue to face ... Alzheimer's disease (AD), which reflects their poor understanding ... diagnosis of the disease, especially in its early ... tests. In 2014, after decades that have ... the medicine world, there are still no disease-modifying ...
(Date:9/1/2014)... 01, 2014 "Women struggle with weight ... daily changes begin as early as 15, if not ... negotiating the ups and downs of hormone related weight ... even healthy sizes seems to rage against the hidden ... woman in her 40's begin to face menopause and ...
Breaking Medicine News(10 mins):Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 2Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 3Health News:Pro Player Health Alliance Confirms Big Name Speakers at 2015 American Sleep and Breathing Academy Conference 4Health News:Family dinners good for teens' mental health, could protect from cyberbullying 2Health News:Family dinners good for teens' mental health, could protect from cyberbullying 3Health News:Train Your Brain to Choose Fruit Salad Over French Fries 2Health News:Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com 2Health News:Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com 3Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 2Health News:Female Hormonal Imbalances - Can’t Seem to Shed Those Extra Pounds? Discussion with Medical Expert Dr. Clairborne on Dr. Carol Francis Talk Radio Today 3
... Pa., Nov. 21 Universal,Health Services, Inc. (NYSE: ... to pay a cash dividend of $0.08 per share ... December 3, 2007., Universal Health Services, Inc. is ... and behavioral health hospitals, and,ambulatory centers nationwide and in ...
... counters idea that seniors are by nature sedentary , WEDNESDAY, ... believe that becoming less active is just a normal part ... to dispel such notions. , The program led to a ... of walking participants did each week, according to the leaders ...
... egg follicles, mouse study shows , , WEDNESDAY, Nov. 21 ... by which a mother,s smoking before and after pregnancy ... two-thirds. , Cigarette smoking during pregnancy has been shown ... woman,s offspring, but this is the first study to ...
... at St. Jude Children,s Research Hospital have discovered a ... amok and damaging the body. The finding could lead ... vaccines; for autoimmune diseases, such as Type 1 diabetes; ... (IBD) and asthma. , The St. Jude team ...
... would you do if you,suddenly found yourself unable to ... a drinker, exercised and got an adequate amount of,sleep ... suffered a stroke. In his new,book, "My Glitch: Personal ... -- http://www.authorhouse.com ), Beel shares his,experiences of being ...
... 8 a.m. CT, MINNEAPOLIS, Nov. 21 Vital ... enterprise-wide advanced,visualization and analysis solutions, will Webcast its analyst ... of the Radiological,Society of North America (RSNA), on Monday, ... D. Miller, president and chief executive officer, and Michael ...
Cached Medicine News:Health News:Aging Isn't About Slowing Down, Experts Say 2Health News:Smoking Before, After Pregnancy Harms Daughters' Fertility 2Health News:Smoking Before, After Pregnancy Harms Daughters' Fertility 3Health News:Smoking Before, After Pregnancy Harms Daughters' Fertility 4Health News:St. Jude finds molecule that could improve cancer vaccines and therapy for other diseases 2Health News:St. Jude finds molecule that could improve cancer vaccines and therapy for other diseases 3Health News:The Blessing of a Brain Injury: Author Survives Injury to Brain Following Stroke, Uses Injury as Fuel to Overcome Odds 2Health News:Vital Images to Webcast Analyst and Investor Meeting at RSNA on Monday, November 26 2
... Autoref / Ker Accuref K ... inch LCD color monitor. 3 ... range. 2.3 mm Minimum pupil ... light adjuster. Auto start function. ...
... is the child-friendly, portable autorefractor that ... adults. It can perform objective refraction ... cm) away even through glasses and ... and sounds engage the patient throughout ...
Neomycin and Polymyxin B sulfates and Dexamethasone ophthalmic ointment is a multiple dose anti-infective steroid combination in sterile ointment form for topical applications....
Optoelectronic stimulator, "ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Pattern stimulations for ERG and VEP, multifocal stimulations for ERG and VEP, complies with international...
Medicine Products: